drugset / Trial / NCT04456530

Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study

NCT04456530

RandomizedParallel-groupDouble-blindPrevention

Summary

The loss of muscle mass post-surgery confounds recovery efforts and leads to a delay in patient's ability to return to activities. Although the use of testosterone in aging and chronic muscle loss has been investigated, this study could prove short-term use of testosterone efficacious in preventing muscle atrophy due to surgery. We hypothesize that by bracketing an indexed knee surgery with testosterone undecanoate injections, post-surgical quadriceps muscle loss may be minimized. Determination of the effect of intra-muscular (IM) testosterone injections in preventing quadriceps muscle loss are measured by serial MRI and manual measurements of quadriceps cross-section.

Timeline

Start
2020-05-08
Primary completion
2021-12-30
Completion
2022-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Undecanoate Small molecule 750 mg Intramuscular

Indications